君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01877 君实生物

未开盘 04-08 16:08:19

25.420

-0.960

-3.64%

最高26.800	最低24.640	成交量797.94万
今开26.460	昨收26.380	日振幅8.19%
总市值261.06亿	流通市值66.09亿	总股本10.27亿
成交额2.02亿	换手率3.07%	流通股本2.60亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01877","market":"HK","secType":"STK","nameCN":"君实生物","latestPrice":25.42,"timestamp":1775635699003,"preClose":26.38,"halted":0,"volume":7979400,"delay":0,"changeRate":-0.03639120545868072,"floatShares":260000000,"shares":1027000000,"eps":-0.87,"marketStatus":"未开盘","change":-0.96,"latestTime":"04-08 16:08:19","open":26.46,"high":26.8,"low":24.64,"amount":202377813,"amplitude":0.08188,"askPrice":25.42,"askSize":1400,"bidPrice":25.36,"bidSize":4800,"shortable":3,"etf":0,"ttmEps":-0.907,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1775698200000},"marketStatusCode":0,"adr":0,"listingDate":1545580800000,"exchange":"SEHK","adjPreClose":26.38,"openAndCloseTimeList":[[1775611800000,1775620800000],[1775624400000,1775635200000]],"volumeRatio":1.1967441073354312,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"688180","market":"SH","secType":"STK","nameCN":"君实生物","latestPrice":39.23,"timestamp":1775631600000,"preClose":38.85,"halted":0,"volume":20581900,"delay":0,"premium":"-43.47"}},"requestUrl":"/m/hq/s/01877","defaultTab":"news","newsList":[{"id":"2625207586","title":"智通AH统计|4月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2625207586","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625207586?lang=zh_cn&edition=full","pubTime":"2026-04-06 16:15","pubTimestamp":1775463305,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月6日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为592.31%、326.46%、317.05%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-23.42%、-13.10%、-5.05%。其中东北电气、弘业期货、长飞光纤光缆的偏离值位居前三，分别为80.26%、36.35%、36.34%；另外，京城机电股份、山东墨龙、浙江世宝的偏离值位居后三，分别为-36.86%、-29.09%、-20.61%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["01812","EWH","LU0972618739.USD","01330","06613","00568","01033","LU1988902786.USD","06869","03606","03750","01877","02865","03986","02359","00991","LU0918141705.HKD","03143","LU0516422440.USD","03968","01108","LU2097828631.EUR","00187","399300","01276","02009","00553","00895","01057","00300","02338","03678","LU0287142896.SGD","00042","159982","02899","LU0214875030.USD","LU0417516738.SGD","02692","01635","BK1231","02866","BK1161","06865","02768","LU0328353924.USD","02218","00753","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624655531","title":"智通AH统计|4月3日","url":"https://stock-news.laohu8.com/highlight/detail?id=2624655531","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624655531?lang=zh_cn&edition=full","pubTime":"2026-04-03 16:15","pubTimestamp":1775204105,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月3日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为592.31%、326.46%、317.05%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-23.42%、-13.10%、-5.05%。其中东北电气、弘业期货、长飞光纤光缆的偏离值位居前三，分别为73.34%、37.16%、36.98%；另外，京城机电股份、山东墨龙、浙江世宝的偏离值位居后三，分别为-39.85%、-33.45%、-21.56%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1425077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03606","159982","LU0106959298.USD","LU2097828474.EUR","00042","01877","EWH","LU0516423174.USD","02009","00991","LU0634319403.HKD","01349","06613","01276","01057","02865","00187","02359","02899","399300","00553","02218","LU0067412154.USD","LU2177674079.SGD","00981","LU0572944931.SGD","00753","01812","01330","03986","00568","03968","02768","LU1769817096.USD","02338","BK1610","03143","LU0211977185.USD","00300","06869","02692","01635","01033","01108","LU0516422952.EUR","00895","06865","03678","03750"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624314016","title":"中金：国产创新药产业趋势向好 26年学术领域看点较多","url":"https://stock-news.laohu8.com/highlight/detail?id=2624314016","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624314016?lang=zh_cn&edition=full","pubTime":"2026-04-03 10:41","pubTimestamp":1775184094,"startTime":"0","endTime":"0","summary":"中金主要观点如下：研发效率、临床资源优势禀赋，国产创新BD加速、量价齐升NMPA和医药魔方统计显示，2026Q1国内创新药BD总金额超600亿美元，超过2024全年、接近2025全年水平1/2；且平均首付款和平均交易规模均创历史新高。在MNC的积极推动下，多个中国创新资产有望在2026年步入上市申报阶段；基于对国内企业创新能力的认可，多个早期平台化对外合作交易陆续达成。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1424995.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0348784397.USD","BK1191","LU0561508036.HKD","LU1961090484.USD","LU0359202008.SGD","BK1515","LU2476274720.SGD","01276","LU1770034418.SGD","LU0417516738.SGD","01877","LU0348767384.USD","06160","LU0348825331.USD","09926","IE00B543WZ88.USD","06938","06978","LU2399975544.HKD","LU2778985437.USD","159992","IE00B5MMRT66.SGD","BK1574","LU0417516571.SGD","LU0634319403.HKD","LU0417516902.SGD","LU0348766576.USD","LU0307460666.USD","LU2543165471.USD","LU0588546209.SGD","09995","LU1303224171.USD","LU0359201612.USD","LU0348735423.USD","BK1588","LU1720050803.USD","BK1583","BK1161","LU2328871848.SGD","LU1969619763.USD","LU1023057109.AUD","LU1719994722.HKD","BK1500","LU1794554557.SGD","IE00BPRC5H50.USD","LU0348783233.USD","LU0348827113.USD","LU0540923850.HKD","LU0359201885.HKD","LU2488822045.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162829688","title":"君实生物3月股份变动月报表：股本维持不变","url":"https://stock-news.laohu8.com/highlight/detail?id=1162829688","media":"公告速递","labels":["corporation","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1162829688?lang=zh_cn&edition=full","pubTime":"2026-04-02 16:48","pubTimestamp":1775119719,"startTime":"0","endTime":"0","summary":"上海君实生物医药科技股份有限公司于2026年4月2日披露2026年3月股份变动月报表。截至本报告期末，公司股本结构未发生任何新增发行、购回或注销变动，整体保持稳定。其中，H股本月末发行股份数为260,295,700股，A股本月末发行股份数为766,394,171股，库存股份数量均无变化。公司已批准的H股与A股股票期权激励计划亦无行使或授出变动。截至本月末，公司股本总数仍保持不变，暂无其他股份变动事项。公司表示将继续根据规定公布后续进展。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624593216","title":"智通AH统计|4月1日","url":"https://stock-news.laohu8.com/highlight/detail?id=2624593216","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624593216?lang=zh_cn&edition=full","pubTime":"2026-04-01 16:15","pubTimestamp":1775031306,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月1日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为558.54%、327.11%、313.50%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-23.17%、-16.55%、-3.42%。其中龙源电力、弘业期货、东北电气的偏离值位居前三，分别为43.60%、36.16%、25.58%；另外，京城机电股份、浙江世宝、山东墨龙的偏离值位居后三，分别为-39.87%、-22.46%、-19.33%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1423928.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU1008478684.HKD","00338","00916","LU0431992006.USD","01456","03678","02208","03986","LU0516422440.USD","00895","03968","01033","02865","03143","00956","02899","BK1144","03200","LU1023057109.AUD","00568","BK1592","LU0082770016.SGD","01057","BK1147","399300","00300","02359","00553","LU0620787316.HKD","01877","06031","09980","02701","02338","02768","01349","03750","EWH","00042","01108","159982","IE00B0169L03.USD","LU0348735423.USD","LU1282649067.USD","02465","IE00B5MMRT66.SGD","00187","01276","BK1558"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1191705334","title":"君实生物董事长斥资1.006亿元增持330万股H股，持股比例提升","url":"https://stock-news.laohu8.com/highlight/detail?id=1191705334","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1191705334?lang=zh_cn&edition=full","pubTime":"2026-03-31 20:52","pubTimestamp":1774961556,"startTime":"0","endTime":"0","summary":"根据公开信息显示，从2025年4月12日至2026年3月31日期间，君实生物董事长通过市场交易方式，累计增持公司330万股H股。此次增持总金额约为1.006亿元人民币，显示出公司高层对未来发展的坚定信心。\n此次增持行为不仅体现了管理层对公司长期价值的认可，也可能向市场传递积极信号。作为创新药领域的领先企业，君实生物近年来在研发管线方面持续取得突破，此次董事长的大手笔增持进一步强化了投资者对公司的关注度。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01877","BK1515","BK1583","BK0239","BK1161","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2623583819","title":"君实生物：熊俊及其一致行动人持股比例已升至18.24%","url":"https://stock-news.laohu8.com/highlight/detail?id=2623583819","media":"南方财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2623583819?lang=zh_cn&edition=full","pubTime":"2026-03-31 18:33","pubTimestamp":1774953197,"startTime":"0","endTime":"0","summary":"南财智讯3月31日电，君实生物公告，公司控股股东、实际控制人之一兼董事长熊俊及其一致行动人熊凤祥、上海宝盈资产管理有限公司、孟晓君、高淑芳、珠海华朴投资管理有限公司、周玉清、刘小玲、王莉芳，于2025年11月10日至2026年3月31日期间通过集中竞价及港股通等方式合计增持公司股份3,259,495股，占公司总股本的0.32%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603313690573729.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK1161","BK1583","01877","BK1515","BK0239","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1184490371","title":"港股异动 | 创新药板块午后拉升，昭衍新药涨超13%，石药集团涨超11%","url":"https://stock-news.laohu8.com/highlight/detail?id=1184490371","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1184490371?lang=zh_cn&edition=full","pubTime":"2026-03-27 13:05","pubTimestamp":1774587950,"startTime":"0","endTime":"0","summary":"信达生物涨超7%，君实生物、诺诚健华涨超6%。","market":"hk","thumbnail":"https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/85675909dc6c67ee0181339c18bcfdff"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"9b241a979bfd22b774f426314475f336","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01801","09969","01093","06127","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1112843274","title":"港股生物医药板块涨幅居前，康方生物涨超5%，科伦博泰生物涨超4%","url":"https://stock-news.laohu8.com/highlight/detail?id=1112843274","media":"老虎资讯综合","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1112843274?lang=zh_cn&edition=full","pubTime":"2026-03-26 09:54","pubTimestamp":1774490076,"startTime":"0","endTime":"0","summary":"3月26日，$生物(000504)$医药板块涨幅居前，$康方生物(09926)$涨超5%，$科伦博泰(06990)$生物涨超4%，$泰格医药(03347)$、$荣昌生物(09995)$涨超3%，$药明康德(02359)$、$君实生物(01877)$等个股跟涨","market":"us","thumbnail":"https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c","type":0,"news_type":0,"thumbnails":["https://static.tigerbbs.com/6ad7ed6b96b448ffcc5b5501b0dc346c"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"0a8a9829d43b93c325f4de1fe2adcf40","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":true,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0417516571.SGD","LU0348766576.USD","LU2399975544.HKD","03347","LU0348784397.USD","LU0348825331.USD","01877","09926","BK4588","LU2488822045.USD","LU2476274308.USD","LU0348827113.USD","LU1720050803.USD","LU0348767384.USD","LU2476274720.SGD","LU1794554557.SGD","LU0561508036.HKD","LU1961090484.USD","IE00B543WZ88.USD","LU2778985437.USD","LU0417516902.SGD","IE00B5MMRT66.SGD","02162","09995","LU0540923850.HKD","LU0348783233.USD","LU0634319403.HKD","BK4581","BK1574","BK4585","LU0417516738.SGD","IE00BPRC5H50.USD","LU0348735423.USD","BK1161"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622029343","title":"君实生物跌1.75% 2020年上市2募资共86亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2622029343","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622029343?lang=zh_cn&edition=full","pubTime":"2026-03-25 17:04","pubTimestamp":1774429460,"startTime":"0","endTime":"0","summary":"中国经济网北京3月25日讯 君实生物 今日收报32.63元，跌幅1.75%。　　上市首日，君实生物股价最高报220.40元，为上市以来股价最高点。　　君实生物首次公开发行股票募集资金总额为48.36亿元，扣除发行费用后，募集资金净额为44.97亿元，较原计划多17.97亿元。　　君实生物首次公开发行股票发行费用为3.39亿元，其中，保荐及承销费用3.20亿元。　　经计算，君实生物两次募集资金合计86.12亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushijujiao/20260325/32097552.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK1161","01877","688180","BK0239","BK1515","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622042007","title":"君实生物营收涨28％，为何近百亿元亏损的“窟窿”仍未填上？","url":"https://stock-news.laohu8.com/highlight/detail?id=2622042007","media":"华夏时报网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2622042007?lang=zh_cn&edition=full","pubTime":"2026-03-25 13:44","pubTimestamp":1774417440,"startTime":"0","endTime":"0","summary":"　　自2020年上市以来，君实生物累计亏损额已近百亿元。　　Wind数据显示，2020年—2025年，君实生物的净利润分别为-16.69亿元、-7.31亿元、-25.84亿元、-25.36亿元、-13.8亿元、-10.09亿元，6年累计亏损99.09亿元。　　一直以来，高额的研发费用是君实生物的利润“杀手”。　　高承远认为，君实生物的在研产品处于第二梯队，且存在一定风险。　　高承远认为，君实生物拓益20.68亿元销售额、38%增速，在PD-1红海中已属不易，但天花板清晰可见。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-25/doc-inhseqhc9848751.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-03-25/doc-inhseqhc9848751.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688180","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621796529","title":"每周股票复盘：君实生物（688180）董事长增持26.54万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2621796529","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621796529?lang=zh_cn&edition=full","pubTime":"2026-03-22 01:52","pubTimestamp":1774115532,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，君实生物报收于32.4元，较上周的31.0元上涨4.52%。股本股东变化高管增减持2026年3月16日，公司董事长熊俊增持股份26.54万股，占公司总股本0.0258%。公司公告汇总君实生物自愿披露关于控股股东、实际控制人之一兼董事长增持股份进展公告上海君实生物医药科技股份有限公司控股股东、实际控制人之一兼董事长熊俊先生自2025年4月12日起拟12个月内增持公司股份，合计增持金额不低于人民币1亿元，其中A股不低于5000万元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032200000323.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK1515","BK1583","BK1161","688180","01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2621766949","title":"君实生物在宁波成立新科技公司 注册资本1000万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2621766949","media":"证券日报","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2621766949?lang=zh_cn&edition=full","pubTime":"2026-03-21 11:55","pubTimestamp":1774065300,"startTime":"0","endTime":"0","summary":"本报讯（记者袁传玺）天眼查App显示，3月20日，宁波君研弘实生物医药科技有限公司成立，注册资本1000万元，经营范围为技术服务、技术开发、技术咨询、技术交流、技术转让、技术推广，技术进出口，货物进出口。股东信息显示，该公司由君实生物全资持股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603213679570069.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01877","BK0239","BK1583","BK1515","BK1161","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620373402","title":"君实生物（688180）披露2025年度业绩说明会公告，3月20日股价下跌2.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2620373402","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620373402?lang=zh_cn&edition=full","pubTime":"2026-03-20 22:16","pubTimestamp":1774016183,"startTime":"0","endTime":"0","summary":"截至2026年3月20日收盘，君实生物报收于32.4元，较前一交易日下跌2.76%，最新总市值为332.65亿元。该股当日开盘33.32元，最高34.0元，最低32.4元，成交额达5.04亿元，换手率为1.99%。公告显示，公司将于2026年3月27日10:00-11:00通过上证路演中心网络互动方式召开2025年度业绩说明会，介绍公司2025年年度报告的经营成果和财务状况。投资者可于2026年3月26日16:00前通过上证路演中心网站或公司邮箱提交问题。说明会结束后可通过上证路演中心查看会议内容。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026032000043294.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688180","BK1161","BK0239","01877","BK1515","BK1583"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1151941272","title":"异动解读 | 研发管线进展积极叠加控股股东增持，君实生物盘中大涨5.04%","url":"https://stock-news.laohu8.com/highlight/detail?id=1151941272","media":"异动解读","labels":["movement"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1151941272?lang=zh_cn&edition=full","pubTime":"2026-03-17 10:19","pubTimestamp":1773713947,"startTime":"0","endTime":"0","summary":"君实生物今日盘中股价大幅拉升，涨幅一度达到5.04%，引起了市场的广泛关注。消息面上，公司近期召开了业绩说明会，向市场详细披露了其丰富的创新药研发管线进展。这些进展凸显了公司在肿瘤治疗领域的深厚布局和长期增长潜力。与此同时，公司控股股东、实际控制人之一兼董事长持续增持公司股份，截至最新公告日已累计增持金额超1200万元，且增持计划尚未完成，这进一步向市场传递了内部人士对公司未来发展前景的坚定信心。","market":"hk","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_cn","symbols":["01877"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620416592","title":"君实生物：3月13日召开业绩说明会，长江证券、兴业证券等多家机构参与","url":"https://stock-news.laohu8.com/highlight/detail?id=2620416592","media":"证券之星","labels":["conferences"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2620416592?lang=zh_cn&edition=full","pubTime":"2026-03-17 09:16","pubTimestamp":1773710179,"startTime":"0","endTime":"0","summary":"证券之星消息，2026年3月16日君实生物发布公告称公司于2026年3月13日召开业绩说明会，长江证券、兴业证券、中邮证券、中金公司、中泰证券、浙商证券、投资者、广发证券、国联民生证券、国泰海通证券、国金证券、华安证券、开源证券、太平洋证券、瑞银证券参与。JS005注射部位反应发生率仅1%,明显低于同类药物。答：特瑞普利单抗已于中美欧等全球40多个国家和地区获得批准上市。该股最近90天内共有1家机构给出评级，增持评级1家。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031700008475.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"conferences","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK1515","BK0183","BK1583","BK0188","BK0276","BK1161","BK0201","688180","BK0012","000783","BK0028","BK0239","01877","601377"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619246863","title":"君实生物(01877)获董事长熊俊累计增持36.54万股A股","url":"https://stock-news.laohu8.com/highlight/detail?id=2619246863","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619246863?lang=zh_cn&edition=full","pubTime":"2026-03-16 19:57","pubTimestamp":1773662249,"startTime":"0","endTime":"0","summary":"截至本公告披露日，熊俊先生通过上海证券交易所系统以集中竞价方式累计增持公司A股股份36.54万股，约占公司总股本的0.04%，累计成交总额为人民币1220.66万元。本次增持计划尚未实施完毕，熊俊先生将继续按照相关增持计划，在增持计划实施期间内择机增持公司股份。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1414475.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["01877","399300","BK1515","BK1583","BK0239","BK1161","688180","159982"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619431806","title":"君实生物：2025年营收增长28.23%至24.98亿元，商业化药品销售收入与上年同期相比有所增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2619431806","media":"财经网","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619431806?lang=zh_cn&edition=full","pubTime":"2026-03-16 13:07","pubTimestamp":1773637620,"startTime":"0","endTime":"0","summary":"近日，君实生物发布公告称，2025年君实生物实现营业收入24.98亿元，同比增长28.23%；归属于母公司所有者的净利润亏损8.75亿元，上年同期净利润亏损12.81亿元。公司2025年度不进行利润分配，也不进行资本公积转增股本。营业收入同比增长，主要系商业化药品的销售收入与上年同期相比有所增长。归属于上市公司股东的净利润较上年同期亏损减少主要系商业化药品的销售收入与上年同期相比有所增长。\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-16/doc-inhreeew9895503.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/hk/2026-03-16/doc-inhreeew9895503.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["01877","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619712589","title":"君实生物(688180)2月28日股东户数3.8万户，较上期增加8.44%","url":"https://stock-news.laohu8.com/highlight/detail?id=2619712589","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619712589?lang=zh_cn&edition=full","pubTime":"2026-03-14 17:02","pubTimestamp":1773478968,"startTime":"0","endTime":"0","summary":"证券之星消息，近日君实生物披露，截至2026年2月28日公司股东户数为3.8万户，较12月31日增加2953.0户，增幅为8.44%。户均持股数量由上期的2.19万股减少至2.02万股，户均持股市值为68.64万元。在生物制品行业个股中，君实生物股东户数高于行业平均水平，截至2月28日，生物制品行业平均股东户数为3.45万户。从股价来看，2025年12月31日至2026年2月28日，君实生物区间跌幅为0.47%，在此期间股东户数增加2953.0户，增幅为8.44%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026031400013280.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["01877","BK1515","BK1583","BK0239","BK1161","688180"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2619314290","title":"君实生物2025年报：减亏超三成，肿瘤药战场迎双抗分水岭","url":"https://stock-news.laohu8.com/highlight/detail?id=2619314290","media":"21世纪经济报道","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2619314290?lang=zh_cn&edition=full","pubTime":"2026-03-14 11:01","pubTimestamp":1773457288,"startTime":"0","endTime":"0","summary":"21世纪经济报道记者季媛媛在创新药行业依旧处于资本寒冬的“降本增效”主旋律中，君实生物交出了2025年成绩单。3月13日晚间，君实生物（1877.HK，688180.SH）发布的2025年年度报告显示，公司在报告期内实现营业收入24.98亿元，同比增长28.23%；归母净亏损收窄至8.75亿元，同比大幅减亏31.68%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202603143672192095.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202603143672192095.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["688180","BK1515","BK0239","01877","BK1161","BK1583"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://junshipharma.com","stockEarnings":[{"period":"1week","weight":-0.0163},{"period":"1month","weight":0.3407},{"period":"3month","weight":0.0609},{"period":"6month","weight":-0.1406},{"period":"1year","weight":0.9258},{"period":"ytd","weight":0.1912}],"compareEarnings":[{"period":"1week","weight":0.0237},{"period":"1month","weight":0.0191},{"period":"3month","weight":-0.0098},{"period":"6month","weight":-0.0151},{"period":"1year","weight":0.2864},{"period":"ytd","weight":0.0102}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"上海君实生物医药科技股份有限公司是一家主要从事创新驱动生物制药业务的中国公司。该公司主营业务为创新药物的发现、临床研究和开发。该公司的主要产品包括特立普珠单抗注射液、依替维单抗、阿达木单抗注射液等用于治疗恶性肿瘤、自身免疫系统疾病、慢性代谢疾病、神经系统疾病和感染性疾病的药物。该公司还从事重组人源化抗PCSK9单克隆抗体注射液等药物的临床研发。该公司主要为国内外市场提供产品。","yearOnYearQuotes":[{"month":1,"riseRate":0.25,"avgChangeRate":-0.098181},{"month":2,"riseRate":0.75,"avgChangeRate":0.062525},{"month":3,"riseRate":0.75,"avgChangeRate":0.059343},{"month":4,"riseRate":0.875,"avgChangeRate":0.101081},{"month":5,"riseRate":0.428571,"avgChangeRate":0.004505},{"month":6,"riseRate":0.428571,"avgChangeRate":-0.018268},{"month":7,"riseRate":0.571429,"avgChangeRate":-0.014588},{"month":8,"riseRate":0.142857,"avgChangeRate":-0.040587},{"month":9,"riseRate":0.142857,"avgChangeRate":-0.026161},{"month":10,"riseRate":0.285714,"avgChangeRate":-0.004518},{"month":11,"riseRate":0.571429,"avgChangeRate":0.043753},{"month":12,"riseRate":0.571429,"avgChangeRate":0.085319}],"exchange":"SEHK","name":"君实生物","nameEN":"JUNSHI BIO"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.40.0","shortVersion":"4.40.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"君实生物,01877,君实生物股票,君实生物股票老虎,君实生物股票老虎国际,君实生物行情,君实生物股票行情,君实生物股价,君实生物股市,君实生物股票价格,君实生物股票交易,君实生物股票购买,君实生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"君实生物(01877)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供君实生物(01877)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}